Structure

Physi-Chem Properties

Molecular Weight:  376.19
Volume:  391.582
LogP:  2.838
LogD:  1.767
LogS:  -4.431
# Rotatable Bonds:  8
TPSA:  100.9
# H-Bond Aceptor:  6
# H-Bond Donor:  2
# Rings:  2
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.709
Synthetic Accessibility Score:  3.595
Fsp3:  0.571
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.307
MDCK Permeability:  4.154865746386349e-05
Pgp-inhibitor:  0.013
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.049
20% Bioavailability (F20%):  0.029
30% Bioavailability (F30%):  0.006

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.069
Plasma Protein Binding (PPB):  78.15095520019531%
Volume Distribution (VD):  0.168
Pgp-substrate:  14.052854537963867%

ADMET: Metabolism

CYP1A2-inhibitor:  0.022
CYP1A2-substrate:  0.473
CYP2C19-inhibitor:  0.056
CYP2C19-substrate:  0.671
CYP2C9-inhibitor:  0.188
CYP2C9-substrate:  0.957
CYP2D6-inhibitor:  0.003
CYP2D6-substrate:  0.234
CYP3A4-inhibitor:  0.048
CYP3A4-substrate:  0.147

ADMET: Excretion

Clearance (CL):  9.166
Half-life (T1/2):  0.761

ADMET: Toxicity

hERG Blockers:  0.019
Human Hepatotoxicity (H-HT):  0.123
Drug-inuced Liver Injury (DILI):  0.496
AMES Toxicity:  0.01
Rat Oral Acute Toxicity:  0.008
Maximum Recommended Daily Dose:  0.026
Skin Sensitization:  0.041
Carcinogencity:  0.01
Eye Corrosion:  0.006
Eye Irritation:  0.07
Respiratory Toxicity:  0.023

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC472704

Natural Product ID:  NPC472704
Common Name*:   WOXSROLDXSRULX-NHCUHLMSSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  WOXSROLDXSRULX-NHCUHLMSSA-N
Standard InCHI:  InChI=1S/C21H28O6/c1-19(2)11-16(22)12-21(19,4)15-7-5-14(6-8-15)18(25)27-10-9-20(3,26)13-17(23)24/h5-8,26H,9-13H2,1-4H3,(H,23,24)/t20-,21-/m1/s1
SMILES:  CC1(CC(=O)CC1(C)C2=CC=C(C=C2)C(=O)OCCC(C)(CC(=O)O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3581620
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001550] Sesquiterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32768 basidiomycete deconica sp. 471 Species n.a. n.a. n.a. n.a. n.a. PMID[25871540]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1460 Cell Line L929 Mus musculus IC50 > 10.0 ug.mL-1 PMID[489841]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC472704 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9914 High Similarity NPC472703
0.9583 High Similarity NPC472706
0.9032 High Similarity NPC472707
0.8507 High Similarity NPC475413
0.8507 High Similarity NPC474303
0.8507 High Similarity NPC242355
0.8507 High Similarity NPC473497
0.8462 Intermediate Similarity NPC233860
0.8462 Intermediate Similarity NPC239358
0.8462 Intermediate Similarity NPC233692
0.8455 Intermediate Similarity NPC472708
0.845 Intermediate Similarity NPC82712
0.845 Intermediate Similarity NPC272946
0.8397 Intermediate Similarity NPC472248
0.8382 Intermediate Similarity NPC45307
0.8376 Intermediate Similarity NPC249811
0.8333 Intermediate Similarity NPC28836
0.8333 Intermediate Similarity NPC477359
0.8333 Intermediate Similarity NPC311492
0.8333 Intermediate Similarity NPC477368
0.8333 Intermediate Similarity NPC153617
0.8305 Intermediate Similarity NPC469636
0.8284 Intermediate Similarity NPC86772
0.8271 Intermediate Similarity NPC79699
0.8271 Intermediate Similarity NPC477367
0.8271 Intermediate Similarity NPC200154
0.8271 Intermediate Similarity NPC232888
0.8258 Intermediate Similarity NPC477364
0.8244 Intermediate Similarity NPC72915
0.8222 Intermediate Similarity NPC272523
0.8222 Intermediate Similarity NPC325805
0.8209 Intermediate Similarity NPC202729
0.8203 Intermediate Similarity NPC295664
0.8201 Intermediate Similarity NPC170668
0.8195 Intermediate Similarity NPC472250
0.819 Intermediate Similarity NPC301943
0.819 Intermediate Similarity NPC474365
0.8189 Intermediate Similarity NPC223351
0.8168 Intermediate Similarity NPC475508
0.8168 Intermediate Similarity NPC42234
0.816 Intermediate Similarity NPC204784
0.8148 Intermediate Similarity NPC27721
0.8143 Intermediate Similarity NPC205389
0.8134 Intermediate Similarity NPC265459
0.8134 Intermediate Similarity NPC270364
0.8134 Intermediate Similarity NPC475262
0.8134 Intermediate Similarity NPC290833
0.813 Intermediate Similarity NPC149691
0.8116 Intermediate Similarity NPC153214
0.8115 Intermediate Similarity NPC307651
0.8115 Intermediate Similarity NPC474363
0.8102 Intermediate Similarity NPC77493
0.8102 Intermediate Similarity NPC187566
0.8088 Intermediate Similarity NPC170718
0.8088 Intermediate Similarity NPC473301
0.8074 Intermediate Similarity NPC472551
0.8074 Intermediate Similarity NPC472545
0.8074 Intermediate Similarity NPC52523
0.8074 Intermediate Similarity NPC285221
0.8074 Intermediate Similarity NPC194769
0.8074 Intermediate Similarity NPC217673
0.8071 Intermediate Similarity NPC469513
0.8062 Intermediate Similarity NPC246166
0.806 Intermediate Similarity NPC48929
0.806 Intermediate Similarity NPC329913
0.806 Intermediate Similarity NPC126516
0.806 Intermediate Similarity NPC203486
0.8045 Intermediate Similarity NPC477360
0.8043 Intermediate Similarity NPC183540
0.8033 Intermediate Similarity NPC128368
0.8031 Intermediate Similarity NPC50872
0.803 Intermediate Similarity NPC147561
0.803 Intermediate Similarity NPC471832
0.8028 Intermediate Similarity NPC232583
0.8028 Intermediate Similarity NPC25484
0.8028 Intermediate Similarity NPC477099
0.8028 Intermediate Similarity NPC477101
0.8028 Intermediate Similarity NPC477097
0.8017 Intermediate Similarity NPC70624
0.8015 Intermediate Similarity NPC115797
0.8015 Intermediate Similarity NPC51448
0.8015 Intermediate Similarity NPC39549
0.8 Intermediate Similarity NPC127857
0.8 Intermediate Similarity NPC472247
0.8 Intermediate Similarity NPC470765
0.7986 Intermediate Similarity NPC95449
0.7986 Intermediate Similarity NPC82467
0.7986 Intermediate Similarity NPC477094
0.7986 Intermediate Similarity NPC477096
0.7984 Intermediate Similarity NPC228739
0.7984 Intermediate Similarity NPC85511
0.7967 Intermediate Similarity NPC153053
0.7956 Intermediate Similarity NPC9905
0.7956 Intermediate Similarity NPC276652
0.7953 Intermediate Similarity NPC473243
0.7951 Intermediate Similarity NPC321852
0.7949 Intermediate Similarity NPC25458
0.7939 Intermediate Similarity NPC204579
0.7939 Intermediate Similarity NPC110211
0.7939 Intermediate Similarity NPC473220
0.7939 Intermediate Similarity NPC470753
0.7931 Intermediate Similarity NPC203925
0.7931 Intermediate Similarity NPC325497
0.7926 Intermediate Similarity NPC134937
0.7926 Intermediate Similarity NPC324898
0.7926 Intermediate Similarity NPC298547
0.7914 Intermediate Similarity NPC51181
0.791 Intermediate Similarity NPC125153
0.7903 Intermediate Similarity NPC306740
0.7902 Intermediate Similarity NPC125033
0.7899 Intermediate Similarity NPC475660
0.7899 Intermediate Similarity NPC251294
0.7899 Intermediate Similarity NPC275592
0.7899 Intermediate Similarity NPC472547
0.7899 Intermediate Similarity NPC162613
0.7899 Intermediate Similarity NPC97667
0.7899 Intermediate Similarity NPC171207
0.7899 Intermediate Similarity NPC87934
0.7899 Intermediate Similarity NPC100913
0.7899 Intermediate Similarity NPC90614
0.7895 Intermediate Similarity NPC194979
0.7887 Intermediate Similarity NPC132652
0.7886 Intermediate Similarity NPC474176
0.7872 Intermediate Similarity NPC25043
0.7872 Intermediate Similarity NPC134131
0.7869 Intermediate Similarity NPC476003
0.7869 Intermediate Similarity NPC210089
0.7869 Intermediate Similarity NPC260818
0.7868 Intermediate Similarity NPC279637
0.7868 Intermediate Similarity NPC149401
0.7863 Intermediate Similarity NPC275576
0.7863 Intermediate Similarity NPC477366
0.7863 Intermediate Similarity NPC9180
0.7863 Intermediate Similarity NPC476033
0.7863 Intermediate Similarity NPC121272
0.7863 Intermediate Similarity NPC100402
0.7863 Intermediate Similarity NPC476599
0.7862 Intermediate Similarity NPC477098
0.7862 Intermediate Similarity NPC477100
0.7857 Intermediate Similarity NPC45794
0.7851 Intermediate Similarity NPC17417
0.7851 Intermediate Similarity NPC10251
0.7851 Intermediate Similarity NPC265407
0.7851 Intermediate Similarity NPC83628
0.7847 Intermediate Similarity NPC471103
0.7847 Intermediate Similarity NPC51602
0.7846 Intermediate Similarity NPC477362
0.7845 Intermediate Similarity NPC78701
0.7845 Intermediate Similarity NPC35448
0.7842 Intermediate Similarity NPC97947
0.7842 Intermediate Similarity NPC118080
0.7842 Intermediate Similarity NPC224491
0.7842 Intermediate Similarity NPC291599
0.7842 Intermediate Similarity NPC473654
0.7842 Intermediate Similarity NPC41481
0.7842 Intermediate Similarity NPC87448
0.7842 Intermediate Similarity NPC27377
0.7842 Intermediate Similarity NPC472576
0.7842 Intermediate Similarity NPC266374
0.7842 Intermediate Similarity NPC16912
0.784 Intermediate Similarity NPC471616
0.7832 Intermediate Similarity NPC250046
0.7832 Intermediate Similarity NPC60509
0.7832 Intermediate Similarity NPC81698
0.7829 Intermediate Similarity NPC269923
0.7829 Intermediate Similarity NPC167323
0.7817 Intermediate Similarity NPC477095
0.7817 Intermediate Similarity NPC475552
0.7817 Intermediate Similarity NPC478263
0.781 Intermediate Similarity NPC477358
0.7805 Intermediate Similarity NPC82899
0.7805 Intermediate Similarity NPC270699
0.7803 Intermediate Similarity NPC169913
0.7803 Intermediate Similarity NPC477357
0.7803 Intermediate Similarity NPC477365
0.7797 Intermediate Similarity NPC188895
0.7797 Intermediate Similarity NPC304873
0.7794 Intermediate Similarity NPC474608
0.7787 Intermediate Similarity NPC251854
0.7787 Intermediate Similarity NPC196246
0.7787 Intermediate Similarity NPC214067
0.7787 Intermediate Similarity NPC93084
0.7786 Intermediate Similarity NPC472546
0.7786 Intermediate Similarity NPC192658
0.7778 Intermediate Similarity NPC198455
0.7778 Intermediate Similarity NPC217621
0.7778 Intermediate Similarity NPC165260
0.7778 Intermediate Similarity NPC161239
0.7778 Intermediate Similarity NPC238370
0.7778 Intermediate Similarity NPC146351
0.7778 Intermediate Similarity NPC7095
0.7778 Intermediate Similarity NPC112216
0.7778 Intermediate Similarity NPC91730
0.777 Intermediate Similarity NPC477904
0.777 Intermediate Similarity NPC183270
0.7769 Intermediate Similarity NPC56493
0.7769 Intermediate Similarity NPC20485
0.7762 Intermediate Similarity NPC217918
0.776 Intermediate Similarity NPC221275
0.776 Intermediate Similarity NPC476357

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC472704 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.803 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.8017 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7872 Intermediate Similarity NPD7236 Approved
0.7851 Intermediate Similarity NPD2182 Approved
0.7829 Intermediate Similarity NPD6287 Discontinued
0.7724 Intermediate Similarity NPD7239 Suspended
0.7674 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7669 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD7008 Discontinued
0.7619 Intermediate Similarity NPD5951 Approved
0.7619 Intermediate Similarity NPD690 Clinical (unspecified phase)
0.7606 Intermediate Similarity NPD4628 Phase 3
0.7561 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7559 Intermediate Similarity NPD4198 Discontinued
0.7521 Intermediate Similarity NPD164 Approved
0.7519 Intermediate Similarity NPD9545 Approved
0.7481 Intermediate Similarity NPD7457 Clinical (unspecified phase)
0.7479 Intermediate Similarity NPD1238 Approved
0.7479 Intermediate Similarity NPD2066 Phase 3
0.7436 Intermediate Similarity NPD1693 Approved
0.7407 Intermediate Similarity NPD6085 Phase 2
0.7407 Intermediate Similarity NPD5740 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD7702 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD7799 Discontinued
0.7383 Intermediate Similarity NPD6599 Discontinued
0.7381 Intermediate Similarity NPD1609 Clinical (unspecified phase)
0.7364 Intermediate Similarity NPD9493 Approved
0.7319 Intermediate Similarity NPD3764 Approved
0.7295 Intermediate Similarity NPD1931 Clinical (unspecified phase)
0.7295 Intermediate Similarity NPD1929 Approved
0.7295 Intermediate Similarity NPD6647 Phase 2
0.7295 Intermediate Similarity NPD1930 Approved
0.7273 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.7266 Intermediate Similarity NPD2652 Approved
0.7266 Intermediate Similarity NPD2650 Approved
0.7266 Intermediate Similarity NPD7961 Discontinued
0.7265 Intermediate Similarity NPD1088 Approved
0.7255 Intermediate Similarity NPD7058 Phase 2
0.7255 Intermediate Similarity NPD7057 Phase 3
0.7239 Intermediate Similarity NPD3972 Approved
0.7214 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7213 Intermediate Similarity NPD1932 Approved
0.7209 Intermediate Similarity NPD2629 Approved
0.7177 Intermediate Similarity NPD5048 Discontinued
0.7165 Intermediate Similarity NPD4141 Clinical (unspecified phase)
0.7162 Intermediate Similarity NPD2532 Approved
0.7162 Intermediate Similarity NPD2534 Approved
0.7162 Intermediate Similarity NPD2533 Approved
0.7153 Intermediate Similarity NPD2346 Discontinued
0.7143 Intermediate Similarity NPD1778 Approved
0.7133 Intermediate Similarity NPD2799 Discontinued
0.7132 Intermediate Similarity NPD6010 Discontinued
0.7121 Intermediate Similarity NPD7741 Discontinued
0.712 Intermediate Similarity NPD6685 Approved
0.7114 Intermediate Similarity NPD6273 Approved
0.7111 Intermediate Similarity NPD9717 Approved
0.7097 Intermediate Similarity NPD1237 Approved
0.7094 Intermediate Similarity NPD1090 Approved
0.7094 Intermediate Similarity NPD1089 Approved
0.7094 Intermediate Similarity NPD9256 Approved
0.7094 Intermediate Similarity NPD1086 Approved
0.7094 Intermediate Similarity NPD9258 Approved
0.7087 Intermediate Similarity NPD2067 Discontinued
0.7083 Intermediate Similarity NPD1989 Approved
0.7083 Intermediate Similarity NPD1551 Phase 2
0.7071 Intermediate Similarity NPD2313 Discontinued
0.7059 Intermediate Similarity NPD5122 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7054 Intermediate Similarity NPD6858 Approved
0.7054 Intermediate Similarity NPD7094 Approved
0.705 Intermediate Similarity NPD6832 Phase 2
0.7047 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD7610 Discontinued
0.7029 Intermediate Similarity NPD2798 Approved
0.7014 Intermediate Similarity NPD7033 Discontinued
0.7014 Intermediate Similarity NPD4308 Phase 3
0.7013 Intermediate Similarity NPD7819 Suspended
0.7009 Intermediate Similarity NPD800 Approved
0.7008 Intermediate Similarity NPD2329 Discontinued
0.7007 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.6993 Remote Similarity NPD1607 Approved
0.6993 Remote Similarity NPD3528 Clinical (unspecified phase)
0.6992 Remote Similarity NPD7009 Phase 2
0.698 Remote Similarity NPD6799 Approved
0.6974 Remote Similarity NPD3226 Approved
0.6974 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6974 Remote Similarity NPD7458 Discontinued
0.6966 Remote Similarity NPD2935 Discontinued
0.696 Remote Similarity NPD5909 Discontinued
0.6953 Remote Similarity NPD1317 Discontinued
0.695 Remote Similarity NPD411 Approved
0.6944 Remote Similarity NPD2567 Approved
0.6944 Remote Similarity NPD2569 Approved
0.6923 Remote Similarity NPD230 Phase 1
0.6918 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6918 Remote Similarity NPD6005 Phase 3
0.6918 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6918 Remote Similarity NPD6004 Phase 3
0.6918 Remote Similarity NPD6002 Phase 3
0.6918 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6917 Remote Similarity NPD1202 Approved
0.6906 Remote Similarity NPD5647 Approved
0.6903 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6901 Remote Similarity NPD7713 Phase 3
0.6897 Remote Similarity NPD1510 Phase 2
0.6897 Remote Similarity NPD7305 Phase 1
0.6897 Remote Similarity NPD9259 Approved
0.6897 Remote Similarity NPD9257 Approved
0.6892 Remote Similarity NPD7003 Approved
0.6884 Remote Similarity NPD1876 Approved
0.6883 Remote Similarity NPD7411 Suspended
0.688 Remote Similarity NPD5738 Clinical (unspecified phase)
0.688 Remote Similarity NPD5765 Approved
0.6871 Remote Similarity NPD970 Clinical (unspecified phase)
0.6861 Remote Similarity NPD6637 Approved
0.6861 Remote Similarity NPD1608 Approved
0.6853 Remote Similarity NPD4307 Phase 2
0.6853 Remote Similarity NPD1240 Approved
0.6849 Remote Similarity NPD2796 Approved
0.6838 Remote Similarity NPD1087 Approved
0.6835 Remote Similarity NPD1203 Approved
0.6831 Remote Similarity NPD3268 Approved
0.6829 Remote Similarity NPD9495 Approved
0.6815 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6797 Remote Similarity NPD9264 Approved
0.6797 Remote Similarity NPD9267 Approved
0.6797 Remote Similarity NPD9263 Approved
0.6788 Remote Similarity NPD8368 Discontinued
0.6786 Remote Similarity NPD1019 Discontinued
0.6783 Remote Similarity NPD6663 Approved
0.6779 Remote Similarity NPD3750 Approved
0.6779 Remote Similarity NPD8166 Discontinued
0.6772 Remote Similarity NPD7075 Discontinued
0.6766 Remote Similarity NPD8407 Phase 2
0.6765 Remote Similarity NPD5306 Approved
0.6765 Remote Similarity NPD5305 Approved
0.6765 Remote Similarity NPD5126 Approved
0.6765 Remote Similarity NPD5125 Phase 3
0.6757 Remote Similarity NPD1549 Phase 2
0.675 Remote Similarity NPD1239 Approved
0.6744 Remote Similarity NPD74 Approved
0.6744 Remote Similarity NPD9266 Approved
0.6738 Remote Similarity NPD5736 Approved
0.6735 Remote Similarity NPD5405 Approved
0.6735 Remote Similarity NPD5406 Approved
0.6735 Remote Similarity NPD5408 Approved
0.6735 Remote Similarity NPD5404 Approved
0.6718 Remote Similarity NPD6912 Phase 3
0.6718 Remote Similarity NPD9508 Approved
0.6715 Remote Similarity NPD4106 Approved
0.6715 Remote Similarity NPD4136 Approved
0.6715 Remote Similarity NPD4135 Approved
0.6714 Remote Similarity NPD2797 Approved
0.6713 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6713 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6711 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6711 Remote Similarity NPD2800 Approved
0.6711 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6709 Remote Similarity NPD7768 Phase 2
0.6692 Remote Similarity NPD4233 Approved
0.6692 Remote Similarity NPD4766 Approved
0.6692 Remote Similarity NPD4234 Approved
0.6691 Remote Similarity NPD182 Clinical (unspecified phase)
0.669 Remote Similarity NPD447 Suspended
0.669 Remote Similarity NPD1899 Clinical (unspecified phase)
0.669 Remote Similarity NPD6355 Discontinued
0.6689 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6689 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6689 Remote Similarity NPD2344 Approved
0.6688 Remote Similarity NPD5761 Phase 2
0.6688 Remote Similarity NPD5760 Phase 2
0.6686 Remote Similarity NPD8434 Phase 2
0.6667 Remote Similarity NPD8032 Phase 2
0.6667 Remote Similarity NPD4807 Approved
0.6667 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4806 Approved
0.6667 Remote Similarity NPD7714 Approved
0.6667 Remote Similarity NPD3748 Approved
0.6667 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6667 Remote Similarity NPD3749 Approved
0.6667 Remote Similarity NPD3673 Approved
0.6667 Remote Similarity NPD5277 Phase 2
0.6667 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4110 Phase 3
0.6667 Remote Similarity NPD3672 Approved
0.6667 Remote Similarity NPD7715 Approved
0.6645 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6643 Remote Similarity NPD2199 Approved
0.6643 Remote Similarity NPD2198 Approved
0.6643 Remote Similarity NPD1283 Approved
0.6642 Remote Similarity NPD3019 Approved
0.6642 Remote Similarity NPD2932 Approved
0.6642 Remote Similarity NPD17 Approved
0.6638 Remote Similarity NPD9491 Approved
0.6626 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6624 Remote Similarity NPD6801 Discontinued
0.6623 Remote Similarity NPD5403 Approved
0.6623 Remote Similarity NPD920 Approved
0.6622 Remote Similarity NPD6100 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data